- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
InflaRx N.V. (IFRX)
InflaRx N.V. stock price live, this page displays NASDAQ IFRX stock exchange data. View the IFRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the InflaRx N.V. real time stock price chart below.
What Is the InflaRx N.V. Stock Price Today?
The InflaRx N.V. stock price today is 1.040.
What Is the Stock Symbol for InflaRx N.V.?
The stock symbol for InflaRx N.V. is ""IFRX.""
What Stock Exchange Does InflaRx N.V. Trade On?
InflaRx N.V. is listed and trades on the NASDAQ stock exchange.
Is InflaRx N.V. a Good Stock to Buy?
Determining whether InflaRx N.V.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IFRX quote. (ISIN: NL0012661870)
What Is the InflaRx N.V. Stock Price Today?
The InflaRx N.V. stock price today is 1.040.
What Is the Stock Symbol for InflaRx N.V.?
The stock symbol for InflaRx N.V. is ""IFRX.""
What Stock Exchange Does InflaRx N.V. Trade On?
InflaRx N.V. is listed and trades on the NASDAQ stock exchange.
Is InflaRx N.V. a Good Stock to Buy?
Determining whether InflaRx N.V.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IFRX quote. (ISIN: NL0012661870)
NASDAQ
Currency in USD
1.040
+0.020(+1.96%)
Real-time Data·
Fair Value
An estimate of a InflaRx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.990
1.050
52 wk Range
0.711
2.815
IFRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a InflaRx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9901.050
52 wk Range
0.7112.815
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IFRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a InflaRx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
11.668
Upside
+1,021.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
InflaRx N.V. Company Profile
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company’s C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company develops INF904, an oral, small molecule drug candidate for the chronic inflammatory and autoimmune diseases; IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases; and Gohibic (vilobelimab) for the treatment of COVID-19 and broader ARDS. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.
Compare IFRX to Peers and Sector
Metrics to compare | IFRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIFRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −1.5x | −0.6x | |
PEG Ratio | −0.04 | 0.01 | 0.00 | |
Price/Book | 1.3x | 1.1x | 2.6x | |
Price / LTM Sales | 941.6x | 13.4x | 3.3x | |
Upside (Analyst Target) | - | 42.4% | 41.4% | |
Fair Value Upside | Unlock | 8.6% | 6.0% | Unlock |
Analyst Ratings
7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.668
(+1,021.89% Upside)
Earnings
Latest Release
Oct 30, 2025
EPS / Forecast
-0.18 / -0.1511
Revenue / Forecast
23.80K / 72.33K
People Also Watch
FAQ
What Is the InflaRx (IFRX) Premarket Price Today?
The InflaRx (IFRX) premarket price is 1.010. Premarket price change units: -0.010. Premarket percentage change: -0.980%. Premarket volume: 45,450.000. Current date: 04 Dec 2025. Previous close: 1.020
What Stock Exchange Does InflaRx Trade On?
InflaRx is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for InflaRx?
The stock symbol for InflaRx is "IFRX."
What Is the InflaRx (IFRX) Afterhours Price Today? (Afterhours variable test: 1.060) Current Date: 04 Dec 2025
After hours price: 1.060. After hours price change (units): 0.040. Price change percentage: 3.920%
What Is the InflaRx Market Cap?
As of today, InflaRx market cap is 68.76M.
What Is InflaRx's Earnings Per Share (TTM)?
The InflaRx EPS (TTM) is -0.62.
When Is the Next InflaRx Earnings Date?
InflaRx will release its next earnings report on 18 Mar 2026.
From a Technical Analysis Perspective, Is IFRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has InflaRx Stock Split?
InflaRx has split 0 times.
How Many Employees Does InflaRx Have?
InflaRx has 74 employees.
What is the current trading status of InflaRx (IFRX)?
As of 04 Dec 2025, InflaRx (IFRX) is trading at a price of 1.040, with a previous close of 1.020. The stock has fluctuated within a day range of 0.990 to 1.050, while its 52-week range spans from 0.711 to 2.815.
What Is InflaRx (IFRX) Price Target According to Analysts?
The average 12-month price target for InflaRx is USD11.66768854, with a high estimate of USD24.21494347 and a low estimate of USD5.04487703. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,021.89% Upside potential.
What Is the IFRX Premarket Price?
IFRX's last pre-market stock price is 1.010. The pre-market share volume is 45,450.000, and the stock has decreased by -0.010, or -0.980%.
What Is the IFRX After Hours Price?
IFRX's last after hours stock price is 1.060, the stock has decreased by 0.040, or 3.920%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.